Meeting of the National Vaccine Advisory Committee, 54268-54269 [E7-18758]

Download as PDF 54268 Federal Register / Vol. 72, No. 184 / Monday, September 24, 2007 / Notices Department of Health and Human Services. SUPPLEMENTARY INFORMATION: The award is cancelled at this time to utilize recent and planned technical assessments by HHS experts to guide subsequent HHS action. Dated: September 17, 2007. Mary Lou Valdez, Deputy Director, Office of Global Health Affairs, U.S. Department of Health and Human Services. [FR Doc. E7–18763 Filed 9–21–07; 8:45 am] BILLING CODE 4150–38–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Announcement of Availability of Funds for a Cooperative Agreement To Provide Basic Medical Education Supportive of Maternal-Child Health at Kabul Medical University (KMU) and Clinical Training in Obstetrics and Gynecology to Resident Physicians and Refresher Training to Attending Physicians at the Rabia Balkhi Women’s Hospital; Cancellation Department of Health and Human Services, Office of the Secretary. ACTION: Notice; cancellation. AGENCY: rfrederick on PROD1PC67 with NOTICES SUMMARY: The Department of Health and Human Services published a document in the Federal Register of August 16, 2007, Vol. 72, No. 158, pages 46073 through 46082. The notice announced the sole source award of funds to provide Basic Medical Education Supportive of Maternal-Child Health at Kabul Medical University (KMU) and Clinical Training in Obstetrics and Gynecology to Resident Physicians and Refresher Training to Attending Physicians at the Rabia Balkhi Women’s Hospital. This award is being withdrawn. FOR FURTHER INFORMATION CONTACT: Christopher J. Hickey, Ph.D., Acting Director, Office of Asia and the Pacific, Office of Global Health Affairs, U.S. Department of Health and Human Services. SUPPLEMENTARY INFORMATION: The award is cancelled at this time to utilize recent and planned technical assessments by HHS experts to guide subsequent HHS action. Dated: September 17, 2007. Mary Lou Valdez, Deputy Director, Office of Global Health Affairs, U.S. Department of Health and Human Services. [FR Doc. E7–18756 Filed 9–21–07; 8:45 am] BILLING CODE 4150–38–P VerDate Aug<31>2005 14:43 Sep 21, 2007 Jkt 211001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Secretary’s Advisory Committee on Human Research Protections Department of Health and Human Services, Office of the Secretary, Office of Public Health and Science. ACTION: Notice. AGENCY: SUMMARY: Pursuant to Section 10(a) of the Federal Advisory Committee Act, U.S.C. Appendix 2, notice is hereby given that the Secretary’s Advisory Committee on Human Research Protections (SACHRP) will hold its fourteenth meeting. The meeting will be open to the public. DATES: The meeting will be held on Monday, October 29, 2007, from 8:30 a.m. until 4:30 p.m. and Tuesday, October 30, 2007, from 8:30 a.m. until 4:30 p.m. ADDRESSES: The Sheraton National Hotel, 900 South Orme Street, Arlington, Virginia 22204. Phone: 703– 521–1900. FOR FURTHER INFORMATION CONTACT: Ivor Pritchard, PhD., Acting Director, Office for Human Research Protections (OHRP), or Kevin Prohaska, D.O., Acting Executive Director, Secretary’s Advisory Committee on Human Research Protections; U.S. Department of Health and Human Services, 1101 Wootton Parkway, Suite 200, Rockville, Maryland 20852; 240–453–8231; fax: 240–453–6909; e-mail address: sachrp@osophs.dhhs.gov. Under the authority of 42 U.S.C. 217a, Section 222 of the Public Health Service Act, as amended, SACHRP was established to provide expert advice and recommendations to the Secretary of Health and Human Services and the Assistant Secretary for Health on issues and topics pertaining to or associated with the protection of human research subjects. On October 29, 2007, SACHRP will receive and discuss updated information and reports from the Subpart A Subcommittee and the Subcommittee on Inclusion of Individuals with Impaired DecisionMaking in Research. The Subpart A Subcommittee addresses issues involving the application of subpart A of 45 CFR part 46 in the current research environment. This subcommittee was established by SACHRP at its October 4–5, 2006, meeting. The Subcommittee on Inclusion of Individuals with Impaired Decision-Making in Research is charged with developing recommendations for consideration by SUPPLEMENTARY INFORMATION: PO 00000 Frm 00036 Fmt 4703 Sfmt 4703 SACHRP about whether guidance and/ or additional regulations are needed for research involving individuals with impaired decision-making capacity. This subcommittee was formed as a result of discussions during the July 31– August 1, 2006, SACHRP meeting. On October 30, 2007, the Committee will receive presentations and hear discussions from representatives on two different panels. The first panel will examine human-subjects protections related issues facing institutions participating in Clinical and Translational Science Awards of the National Institutes of Health. The second panel will examine humansubjects protections related issues relative to research in the setting of natural and/or man-made catastrophes and other such emergencies. Public attendance at the meeting is limited to space available. Individuals who plan to attend the meeting and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the designated contact persons. Members of the public will have the opportunity to provide comments on both days of the meeting. Public comment will be limited to five minutes per speaker. Any members of the public who wish to have printed materials distributed to SACHRP members for this scheduled meeting should submit materials to the Acting Executive Director, SACHRP, prior to the close of business Friday, October 19, 2007. Information about SACHRP and the draft meeting agenda will be posted on the SACHRP Web site at: https:// www.hhs.gov/ohrp/sachrp/. Dated: September 19, 2007. Ivor A. Pritchard, Acting Director, Office for Human Research Protections, Acting Executive Secretary, Secretary’s Advisory Committee on Human Research Protections. [FR Doc. E7–18757 Filed 9–21–07; 8:45 am] BILLING CODE 4150–36–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the National Vaccine Advisory Committee Department of Health and Human Services, Office of the Secretary. ACTION: Notice. AGENCY: SUMMARY: As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (DHHS) is hereby giving notice that the National Vaccine Advisory E:\FR\FM\24SEN1.SGM 24SEN1 rfrederick on PROD1PC67 with NOTICES Federal Register / Vol. 72, No. 184 / Monday, September 24, 2007 / Notices Committee (NVAC) will hold a meeting. The meeting is open to the public. DATES: The meeting will be held on October 22, 2007, from 9 a.m. to 5 p.m., and on October 23, 2007, from 9 a.m. to 1:30 p.m. ADDRESSES: Department of Health and Human Services; Hubert H. Humphrey Building, Room 800; 200 Independence Avenue, SW., Washington, DC 20201. FOR FURTHER INFORMATION, CONTACT: Ms. Emma English, Program Analyst, National Vaccine Program Office, Department of Health and Human Services, Room 443–H Hubert H. Humphrey Building, 200 Independence Avenue, SW., Washington, DC 20201; (202) 690–5566, nvpo@hhs.gov. SUPPLEMENTARY INFORMATION: Pursuant to section 2101 of the Public Service Act (42 U.S.C. section 300aa–1), the Secretary of Health and Human Services was mandated to establish the National Vaccine Program to achieve optimal prevention of human infectious diseases through immunization and to achieve optimal prevention against adverse reactions to vaccines. The National Vaccine Advisory Committee was established to provide advice and make recommendations to the Assistant Secretary for Health, as the Director of the National Vaccine Program, on matters related to the program’s responsibilities. Topics to be discussed at the meeting include adult and adolescent immunization, pandemic vaccine prioritization, vaccine financing, vaccine stockpiles, and other Departmental vaccine priorities. Subcommittee meetings will be held on the afternoon of October 22, 2007. A tentative agenda is currently available on the NVAC Web site: https:// www.hhs.gov/nvpo/nvac. In anticipation of a discussion regarding the Committee’s draft document ‘‘Mandates for Adolescent Immunizations,’’ developed by the Adolescent Immunization Working Group, the Committee invites the public to submit written comments to the Executive Secretary, NVAC, through the contact person listed above. Written comment must be received by close of business on October 9, 2007. Additionally, members of the public will be given the opportunity to participate in the discussion on October 22, 2007. Public comment will be limited to five minutes per speaker. A copy of this draft document can be found at (https://www.hhs.gov/nvpo) or by contacting the contact person identified above. Public attendance at the meeting is limited to space available. Individuals VerDate Aug<31>2005 14:43 Sep 21, 2007 Jkt 211001 must provide a photo ID for entry into the Humphrey Building. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the designated contact person. Members of the public will have the opportunity to provide comments at the meeting. Public comment will be limited to five minutes per speaker. Any members of the public who wish to have printed material distributed to NVAC members should submit materials to the Executive Secretary, NVAC, through the contact person listed above prior to close of business October 16, 2007. Preregistration is required for both public attendance and comment. Any individual who wishes to attend the meeting and/or participate in the public comment session should e-mail nvpo@hhs.gov or call 202–690–5566. Dated: September 19, 2007. Bruce Gellin, Director, National Vaccine Program Office. [FR Doc. E7–18758 Filed 9–21–07; 8:45 am] BILLING CODE 4150–44–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National Center for Injury Prevention and Control Initial Review Group: Notice of Charter Renewal This gives notice under the Federal Advisory Committee Act (Pub. L. 92– 463) of October 6, 1972, that the National Center for Injury Prevention and Control Initial Review Group, Centers for Disease Control and Prevention, Department of Health and Human Services, has been renewed for a 2-year period through August 20, 2009. For information, contact Jane Suen, Ph.D., Executive Secretary, National Center for Injury Prevention and Control Initial Review Group, Centers for Disease Control and Prevention, Department of Health and Human Services, 4770 Buford Highway, Mailstop K02, Atlanta, Georgia 30341, telephone 770/488–4281 or fax 770/ 488–2489. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. PO 00000 Frm 00037 Fmt 4703 Sfmt 4703 54269 Dated: September 17, 2007. Elaine L. Baker, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E7–18748 Filed 9–21–07; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Board on Radiation and Worker Health: Notice of Charter Renewal This gives notice under the Federal Advisory Committee Act (Pub. L. 92– 463) of October 6, 1972, that the Advisory Board on Radiation and Worker Health, Centers for Disease Control and Prevention (CDC), Department of Health and Human Services, has been renewed for a 2-year period through August 3, 2009. For information, contact Lewis Wade, Ph.D., Executive Secretary, National Institute for Occupational Safety and Health, CDC, 4976 Columbia Parkway, Cincinnati, Ohio 45226, Telephone (513) 533–6825, Fax (513) 533–6826. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: September 17, 2007. Elaine L. Baker, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E7–18749 Filed 9–21–07; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Proposed Collection; Comment Request; Quality of Life Outcomes in Neurological Disorders SUMMARY: In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the National Institute of Neurological Disorders and Stroke (NINDS), the National Institutes of Health (NIH) will publish periodic summaries of proposed E:\FR\FM\24SEN1.SGM 24SEN1

Agencies

[Federal Register Volume 72, Number 184 (Monday, September 24, 2007)]
[Notices]
[Pages 54268-54269]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-18758]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the National Vaccine Advisory Committee

AGENCY: Department of Health and Human Services, Office of the 
Secretary.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the 
Department of Health and Human Services (DHHS) is hereby giving notice 
that the National Vaccine Advisory

[[Page 54269]]

Committee (NVAC) will hold a meeting. The meeting is open to the 
public.

DATES: The meeting will be held on October 22, 2007, from 9 a.m. to 5 
p.m., and on October 23, 2007, from 9 a.m. to 1:30 p.m.

ADDRESSES: Department of Health and Human Services; Hubert H. Humphrey 
Building, Room 800; 200 Independence Avenue, SW., Washington, DC 20201.

FOR FURTHER INFORMATION, CONTACT: Ms. Emma English, Program Analyst, 
National Vaccine Program Office, Department of Health and Human 
Services, Room 443-H Hubert H. Humphrey Building, 200 Independence 
Avenue, SW., Washington, DC 20201; (202) 690-5566, nvpo@hhs.gov.

SUPPLEMENTARY INFORMATION: Pursuant to section 2101 of the Public 
Service Act (42 U.S.C. section 300aa-1), the Secretary of Health and 
Human Services was mandated to establish the National Vaccine Program 
to achieve optimal prevention of human infectious diseases through 
immunization and to achieve optimal prevention against adverse 
reactions to vaccines. The National Vaccine Advisory Committee was 
established to provide advice and make recommendations to the Assistant 
Secretary for Health, as the Director of the National Vaccine Program, 
on matters related to the program's responsibilities.
    Topics to be discussed at the meeting include adult and adolescent 
immunization, pandemic vaccine prioritization, vaccine financing, 
vaccine stockpiles, and other Departmental vaccine priorities. 
Subcommittee meetings will be held on the afternoon of October 22, 
2007. A tentative agenda is currently available on the NVAC Web site: 
https://www.hhs.gov/nvpo/nvac.
    In anticipation of a discussion regarding the Committee's draft 
document ``Mandates for Adolescent Immunizations,'' developed by the 
Adolescent Immunization Working Group, the Committee invites the public 
to submit written comments to the Executive Secretary, NVAC, through 
the contact person listed above. Written comment must be received by 
close of business on October 9, 2007. Additionally, members of the 
public will be given the opportunity to participate in the discussion 
on October 22, 2007. Public comment will be limited to five minutes per 
speaker. A copy of this draft document can be found at (https://
www.hhs.gov/nvpo) or by contacting the contact person identified above.
    Public attendance at the meeting is limited to space available. 
Individuals must provide a photo ID for entry into the Humphrey 
Building. Individuals who plan to attend and need special assistance, 
such as sign language interpretation or other reasonable 
accommodations, should notify the designated contact person. Members of 
the public will have the opportunity to provide comments at the 
meeting. Public comment will be limited to five minutes per speaker. 
Any members of the public who wish to have printed material distributed 
to NVAC members should submit materials to the Executive Secretary, 
NVAC, through the contact person listed above prior to close of 
business October 16, 2007. Pre-registration is required for both public 
attendance and comment. Any individual who wishes to attend the meeting 
and/or participate in the public comment session should e-mail 
nvpo@hhs.gov or call 202-690-5566.

    Dated: September 19, 2007.
Bruce Gellin,
Director, National Vaccine Program Office.
 [FR Doc. E7-18758 Filed 9-21-07; 8:45 am]
BILLING CODE 4150-44-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.